网站综合信息 www.macrogenics.com
    • 标题:
    • Macrogenics - Homepage 
    • 关键字:
    •  
    • 描述:
    • Research into immunotherapeutics, including monoclonal antibodies, to treat patients with cancer, au 
    • 域名信息
    • 域名年龄:24年11个月28天  注册日期:2000年07月07日  到期时间:2017年07月07日
      邮箱:abuse  电话:+1.8003337680
      注册商:NETWORK SOLUTIONS, LLC. 
    • 服务器空间
    • IP:97.74.215.52 同IP网站14个 详情
      地址:美国 亚利桑那州斯科茨代尔市Go Daddy集团公司
    • 备案信息
    • 备案号: 
    网站收录SEO数据
    • 搜索引擎
    • 收录量
    • 反向链接
    • 其他
    • 百度
    • 0  
    • 104  
    • 快照:无首页快照  
    • Google
    • 607  
    • 26  
    • pr:5  
    • 雅虎
    • 0  
    •  
    •  
    • 搜搜
    • 0  
    •  
    •  
    • 搜狗
    • 0  
    •  
    • 评级:2/10  
    • 360搜索
    • 0  
    •  
    •  
    域名流量Alexa排名
    •  
    • 一周平均
    • 一个月平均
    • 三个月平均
    • Alexa全球排名
    • 2,108,049  
    • 平均日IP
    • 日总PV
    • 人均PV(PV/IP比例)
    • 反向链接
    • 80 
    • dmoz目录收录
    • Science/Biology/Biotechnology/Research_Groups_and_Centers  

    • 流量走势图
    域名注册Whois信息

    macrogenics.com

    域名年龄: 24年11个月28天
    注册时间: 2000-07-07
    到期时间: 2017-07-07
    注 册 商: NETWORK SOLUTIONS, LLC.
    注册邮箱: abuse
    联系电话: +1.8003337680

    获取时间: 2015年01月25日 12:19:35
    Domain Name: MACROGENICS.COM
    Registrar: NETWORK SOLUTIONS, LLC.
    Sponsoring Registrar IANA ID: 2
    Whois Server: whois.networksolutions.com
    Referral URL: http://networksolutions.com
    Name Server: AUTH1.DNS.COGENTCO.COM
    Name Server: AUTH2.DNS.COGENTCO.COM
    Status: clientTransferProhibited http://www.icann.org/epp#clientTransferProhibited
    Updated Date: 2013-03-18
    Creation Date: 2000-07-07
    Expiration Date: 2017-07-07

    >>> Last update of whois database: Sun, 2015-Jan-25 04:22:00 GMT <<<

    For more information on Whois status codes, please visit
    https://www.icann.org/resources/pages/epp-status-codes-2014-06-16-en.

    Domain Name: MACROGENICS.COM
    Registry Domain ID:
    Registrar WHOIS Server: whois.networksolutions.com
    Registrar URL: http://networksolutions.com
    Updated Date: 2013-03-18T13:33:23Z
    Creation Date: 2000-07-07T23:00:00Z
    Registrar Registration Expiration Date: 2017-07-07T04:00:00Z
    Registrar: NETWORK SOLUTIONS, LLC.
    Registrar IANA ID: 2
    Registrar Abuse Contact Email: abuse
    Registrar Abuse Contact Phone: +1.8003337680
    Reseller:
    Domain Status:
    Registry Registrant ID:
    Registrant Name: MACROGENICS, INC.
    Registrant Organization: MACROGENICS, INC.
    Registrant Street: 1500 E GUDE DR
    Registrant City: ROCKVILLE
    Registrant State/Province: MD
    Registrant Postal Code: 20850-5307
    Registrant Country: US
    Registrant Phone: +1.3012515172
    Registrant Phone Ext:
    Registrant Fax: +1.231231234
    Registrant Fax Ext:
    Registrant Email: DrScottKoenig
    Registry Admin ID:
    Admin Name: Marquez, Abraham
    Admin Organization: MACROGENICS, INC.
    Admin Street: 9640 Medical Center Drive
    Admin City: Rockville
    Admin State/Province: MD
    Admin Postal Code: 20850
    Admin Country: US
    Admin Phone: +1.3013542659
    Admin Phone Ext:
    Admin Fax: +1.3012515321
    Admin Fax Ext:
    Admin Email: marqueza
    Registry Tech ID:
    Tech Name: Chancy, Gregory
    Tech Organization: Macfadden & Associates, Inc.
    Tech Street: 1109 Spring Street
    Tech City: Silver Spring
    Tech State/Province: MD
    Tech Postal Code: 20910
    Tech Country: US
    Tech Phone: +1.3015885900
    Tech Phone Ext:
    Tech Fax: +1.3015880390
    Tech Fax Ext:
    Tech Email: gchancy
    Name Server: AUTH1.DNS.COGENTCO.COM
    Name Server: AUTH2.DNS.COGENTCO.COM
    DNSSEC: Unsigned
    URL of the ICANN WHOIS Data Problem Reporting System: http://wdprs.internic.net/
    >>> Last update of whois database: Sun, 2015-Jan-25 04:22:00 GMT <<<

    The data in Networksolutions.com's WHOIS database is provided to you by
    Networksolutions.com for information purposes only, that is, to assist you in
    obtaining information about or related to a domain name registration
    record. Networksolutions.com makes this information available "as is," and
    does not guarantee its accuracy. By submitting a WHOIS query, you
    agree that you will use this data only for lawful purposes and that,
    under no circumstances will you use this data to: (1) allow, enable,
    or otherwise support the transmission of mass unsolicited, commercial
    advertising or solicitations via direct mail, electronic mail, or by
    telephone; or (2) enable high volume, automated, electronic processes
    that apply to Networksolutions.com (or its systems). The compilation,
    repackaging, dissemination or other use of this data is expressly
    prohibited without the prior written consent of Networksolutions.com.
    Networksolutions.com reserves the right to modify these terms at any time.
    By submitting this query, you agree to abide by these terms.
    其他后缀域名
    网站首页快照(纯文字版)
    抓取时间:2014年12月03日 12:28:40
    网址:http://www.macrogenics.com/
    标题:Macrogenics - Homepage
    关键字:
    描述:Research into immunotherapeutics, including monoclonal antibodies, to treat patients with cancer, autoimmune disorders, allergy or infectious diseases.
    主体:
    MacroGenics HomepageAbout UsApproachCapabilitiesSenior ManagementBoard of DirectorsPipelineMargetuximab (HER2)MGA271 (B7-H3)MGD006 (CD123 x CD3)MGD007 (gpA33 x CD3)MGD010 (CD32B x CD79B)Teplizumab (CD3)PlatformsDART™Cancer Stem CellsFc OptimizationPartneringCollaboratorsInvestor RelationsPress ReleasesEvents & PresentationsCorporate GovernanceSenior ManagementBoard of DirectorsCommitteesContact the BoardFinancial InformationSEC FilingsAnnual ReportsQuarterly ResultsKey RatiosStock InformationHistoric Stock LookupInvestment CalculatorDividend HistoryAnalyst CoverageOwnership ProfileInvestor FAQsPublicationsContact UsCareersEmployee Benefits11:29 PM | December 02, 2014Contact Us|Home|Search printGet the Flash Player to see this video.MacroGenics’ mission is to discover, develop and deliver to patients novel biologics for the treatment of cancer, autoimmune disorders and infectious diseases.  Learn MoreMacroGenics' Corporate Fact Sheet Product Pipeline HighlightsView full chartProgram (Target)IndicationPre-Clin.Ph.1Ph.2
    Ph.3
    ONCOLOGY
    Margetuximab  (HER2)Gastroesophageal
    * 
    * 
    * 
    *
    Metastatic Breast
    * 
    * 
    * 
    *
    Solid Tumors
    * 
    * 
    * 
    *
    MGA271  (B7-H3)Solid Tumors
    * 
    * 
    * 
    *
    MGD006  (CD123 x CD3)AML
    * 
    * 
    * 
    *
    MGD007  (gpA33 x CD3)Colorectal
    * 
    * 
    * 
    *
    AUTOIMMUNE
    Teplizumab  (CD3)T1D - At-Risk
    * 
    * 
    * 
    *
    MGD010  (CD32B x CD79B)Lupus, RA
    * 
    * 
    * 
    *
    Overview
    Since its founding in 2000, MacroGenics has applied its world-class antibody capabilities to create life-changing medicines. The company’s innovative product candidates leverage its fully-integrated capabilities and its multiple, proprietary technology platforms.
    Learn more
    Company Highlights
    
    Robust pipeline in oncology and autoimmune disorders
    Partners include Takeda, Gilead, Servier, Pfizer and Boehringer Ingelheim
    Fully-integrated biologics capabilities across product development process 
    Strong financial position
    Experienced leadership and highly collaborative corporate culture 
    Learn more
    Partnering
    MacroGenics is pursuing alliances to participate in development of its proprietary product candidates and technology platforms.Learn more
    Fierce Biotech 2013
    MacroGenics was selected as a 2013 Fierce 15 by Fierce Biotech.  Learn more
    ©2014 MacroGenics, Inc.
    About Us | Platforms | Pipeline | News & Media | Contact Us | Partnering | Sitemap | Home

    © 2010 - 2020 网站综合信息查询 同IP网站查询 相关类似网站查询 网站备案查询网站地图 最新查询 最近更新 优秀网站 热门网站 全部网站 同IP查询 备案查询

    2025-06-24 16:37, Process in 0.0083 second.